Your institution may have access to this item. Find your institution then sign in to continue.
Title
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Authors
Cheetham, S.; Tang, M. J.; Mesak, F.; Kennecke, H.; Owen, D.; Tai, I. T.
Publication
British Journal of Cancer, 2008, Vol 98, Issue 11, p1810